Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Study ID: NCT00830557
Start Date: 2000-10-01
End Date: 2025-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

12000

Intervention / Treatment

medical chart review

survey administration

biospecimen collection

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Using FAPI PET/MRI to Evaluate Prostate Cancer

Study ID: NCT06675357
Start Date: 2025-08
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

FAPI

Positron Emission Tomography (PET)

Magnetic Resonance Imaging

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

Study ID: NCT04343157
Start Date: 2019-05-01
End Date: 2024-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)

Sponsor

Hathon-Gluth-Gluth-Gluth

Source: clinicaltrials.gov

Share:
Add to list

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Study ID: NCT06533748
Start Date: 2025-01-23
End Date: 2034-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

128

Intervention / Treatment

Dexamethasone

Vincristine

InotuMab

Blinatumomab

Underlined

IT MHA

Cyclophosphamide

Cytarabine

Methotrexate

6-Mercaptopurine

CALASPARGE

Etrorior

Thioguanine

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Study ID: NCT06878248
Start Date: 2025-04-17
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Two Component Product CLBR001 + ABBV-461

Sponsor

Calibr, a division of Scripps Research

Source: clinicaltrials.gov

Share:
Add to list

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Study ID: NCT05710848
Start Date: 2023-07-11
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

75

Intervention / Treatment

STM-416

Sponsor

SURGE Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Study ID: NCT02393157
Start Date: 2015-08-21
End Date: 2024-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Obinutuzumab

Liposomal ARA-C

Ifosfamide

Carboplatin

Etoposide

Sponsor

New York Medical College

Source: clinicaltrials.gov

Share:
Add to list

Jump: MR Simulation For Radiation Therapy Master Protocol

Study ID: NCT04545957
Start Date: 2020-10-14
End Date: 2030-10-22
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

86

Intervention / Treatment

MRI Simulator

Radiation Therapy

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Study ID: NCT05085496
Start Date: 2022-04-19
End Date: 2027-09-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Atezolizumab

Stereotactic Body Radiation Therapy

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Study ID: NCT04143516
Start Date: 2019-10-25
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

200

Intervention / Treatment

[18-F]- FDG - PET

Tumor ablation (TA)

PET/CT Scan

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list